S. 4109Reported
Stem Cell Therapeutic and Research Reauthorization Act of 2026
Reauthorizes federal stem cell therapeutic and research programs through 2029 to continue related treatment and research activities
Plain-English overview
What this bill does
Reauthorizes federal stem cell therapeutic and research programs through 2029 to continue related treatment and research activities
Key points
- Extend stem cell programs
Current status
Where it stands
Status
Reported
Latest action
2026-06-17 — Committee on Health, Education, Labor, and Pensions. Ordered to be reported with an amendment in the nature of a substitute favorably.
Related context
Topics and policy areas
undefinedBiological and life sciencesBlood and blood diseasesCell biology and embryologyHealthHealth programs administration and fundingOrgan and tissue donation and transplantation